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Summary
Objective: The present study aims at evaluating, in a rat model of cartilage defect, the potential of various polymers as filling and repair
biomaterials. The macroscopic and histological observations are compared to biochemical parameters in order to appreciate the pertinence
of the latter as suitable criteria in tissue engineering.
Methods: A hydrogel, consisting of hyaluronic acid (HA), covalently substituted by hydrophobic alkyl chains (HA12, HA18) and an alginate
sponge, alone (Asp) or combined with HA (AHAsp) or combined with HA and chondrocytes (HYBsp) were evaluated. Cartilage lesions were
drilled in femoral trochlea of rats. The analyses were performed on trochlea as well as on patella and condyles.
Results: Repairs achieved with hydrogels had a similar macroscopic appearance than those afforded by AHAsp and HYBsp. Best
macroscopic and histological scores were obtained with HA18 and HYBsp in comparison with alginate group (P<0.01 and P<0.02
respectively). Biochemical evaluations confirmed the presence of similar amounts of proteoglycans in the repaired zones and in the controls,
though with different diC4S/diC6S ratios and enhanced HA levels.
Conclusions: Hydrogels or sponges proved to be colonized by cells synthesizing a matrix with a high HA content. The matrix obtained
eventually turns hyaline and takes over the scaffold. The addition of HA and/or chondrocytes to Asp significantly improves the macroscopic
and histological scores (P<0.05 and P<0.02 respectively). However, biochemical parameters are significantly different of those evaluated in
native cartilage. The present study shows that only biochemical parameters allow to discriminate between various biomaterials in tissue
engineering and are essential informations which should be taken into account in addition to macroscopic and histological observations.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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The repair of cartilage is a topic of current actuality for
scientists, surgeons and patients, as well as an important
concern in terms of economic and human costs. Several
centuries after its first observation, this problem of cartilage
repair has not yet found a satisfactory and definitive
answer. The self-repair potential of this tissue is weak since
cartilage is not vascularized and chondrocytes divide16slowly. Full-thickness defects are mostly post-traumatic.
Their natural evolution to mechanically unsatisfactory fibro-
cartilage illustrates the insufficiency of chondrogenesis1.
However, the recruitment of new cells so as to improve the
neo-synthesized cartilage matrix is possible2. Several sites
can provide cells for the induction of cartilage repair:
chondroblasts, perichondrial cells or mesenchymal stem
cells3,4. Hunziker et al.5 also proposed the recruitment of
cells issued from the synovial membrane.
Different methods are currently used for the treatment of
acute cartilage lesions6,7, though with limited success in so
far as they do not prevent the long-term evolution to
osteoarthritis (OA)3,8. Symptomatic and non-specific treat-
ments are nevertheless always useful. For example, con-
tinuous passive motion with initial non-weight-bearing often
generates a clinical improvement which, unfortunately, may
turn out to be not sustainable with time. Similar problems
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BIOMATERIAL PREPARATION
Different types of biomaterials, gels or sponges, were
tested. They were prepared from sodium alginate
(Pronova, Norway, Laminaria hyperborea, ultra-pure,
guluronate/mannuronate ratio=70/30) and from hyaluronic
acid issued from bacterial fermentation (Acros, U.S.A.,
450 000 Da, water 15%). Hydrogels used in the present
study consist in hydrophobically-associating derivatives of
HA, prepared by covalent immobilization of long alkyl
chains (in HA12≈10 moles C12 chains/100 moles glu-
curonic acid unit and in HA18≈3.6 moles C18 chains/100
moles glucuronic acid unit) onto the polysaccharide
hydrophilic bakbone. In semi-dilute solution (C≈5 to 10 g/
L), hydrophobic alkyl chains associate intermolecularly,
leading to the formation of three-dimensional physical net-
works, exhibiting the rheological properties of high viscosity
viscoelastic-to-elastic hydrogels [0≈5×103 to 5×105 fold
that of native HA at the same concentration (10 g/L in
0.15 M NaCl)]52,53–55.
Sponges were prepared by freeze-drying of an aqueous
mixture containing alginate (2% w/v) combined or not with
HA (0.5% w/v) (Asp and AHAsp), as described by Shapiro
et al.56 The physicochemical properties of these porous
scaffolds have been previously studied by Miralles et al.40.
The hybrid biomaterial, based on AHAsp, and seeded with
autologous chondrocytes will be named Hybrid sponge
(HYBsp). Chondrocytes were harvested under general
anesthesia from cartilage of xiphoid appendix. They were
taken and hydrolyzed by pronase E (2 mg/g tissue), 2 h,
37°C (Streptomyces griseum, Sigma, U.S.A.), then by
collagenase B (1.5 mg/g cartilage), 8 h, 37°C (Clostridium
hystolyticum, Boehringer, Germany). After digestion,
chondrocytes were sufficiently numerous to be directly
included in sponges at a level of 5×104 cells/sponge. The
sponges were then cultivated for 15 days before implan-
tation in Nut-Mix F12 medium [500 ml supplemented with
fetal calf serum (55 ml), gentamycine (4 ml), amphotericin
B (0.5 ml) and L-glutamine (6 ml)]. All chemicals were
purchased from Gibco, France.
The sterilization of all biomaterials was carried out by wet
heating (20 min at 121°C).ANIMAL EXPERIMENTATION
A medial parapatellar arthrotomy was performed under
general anesthesia in the left knee of 5–6-week-old rats. A
full-thickness cartilage defect of 1.3 mm diameter was
drilled in the femoral trochlea. Filling of the resulting defect
was achieved by injection of a hydrogel or insertion of a
piece of sponge. After this implantation, the patella was put
back in its place, thus permitting the lesion to be covered
and the biomaterial within to be maintained. The right knee
constituted an individual control of surgery, but without
cartilage lesion. In the same time, all the animals were
intraperitoneally equipped with a transmitter in order to
monitor their spontaneous locomotor activity and their body
temperature during 10 days following the implantation of
biomaterials. The experimental procedure of this bio-
telemetric study was previously described by Gegout-Pottie
et al.57.are met with marrow-stimulation techniques, generally
affording an insufficient clinical outcome9. Other more
sophisticated techniques (mosaicplasty, periostal or peri-
chondrial autografts . . .)8,10 consist in tissue or cell graft-
ing. However, both the limited availability of tissue and the
difficulties of bonding hamper the usability of cartilage
autografts.
Some other methods, proposed for partial or full-
thickness defects, aim at seeding the defect with cells
capable of synthesizing a new cartilage. This latter should
be hyaline, well integrated to native cartilage and exhibit
similar mechanical properties. In the method described by
Brittberg et al.11,12, cell suspensions are transplanted in the
defect and restrained by a sutured periostal flap. However,
the presence of mixed collagen types (I and II) was
sometimes detected by histology and sutures were sus-
pected to cause focal degenerative loss of proteogly-
cans13. This procedure has been recently modified so as to
circumvent these drawbacks14. Yet, the long-term clinical
outcome is unknown.
Hybrid biomaterials are in theory always more
attractive15–19: they surround chondrocytes and offer pro-
tection against immunity rejection and phenotype instability.
They can also present some advantages for the survival,
proliferation, differentiation and synthesis ability of
chondrocytes, thus able to synthesize matrix components
and to reconstitute the hyaline architecture of cartilage20.
Chondrocytes are issued from cartilage by enzymatic
digestion21–23 or from medullar stem cells by differen-
tiation24,25. In most reports, chondrocytes are cultivated in
monolayers for 15–21 days prior to their seeding into a
considered biomaterial. In these conditions, they can pro-
liferate, but they also dedifferentiate into cells presenting a
fibroblastic-like phenotype, accompanied by a decreased
synthesis of type II collagen and proteoglycans26.
Fibroblast-like cells can redifferentiate when placed in a
three-dimensional system27. This latter must be chosen for
its biological and structural properties. It must also be
biocompatible, sterile, porous (to accommodate cell pro-
liferation) and, preferably, bioresorbable. Numerous non-
degradable and degradable polymers, recently reviewed
by Seal et al.28, have been studied. For example,
some biomaterials are naturally-derived materials like
thrombin29,30, collagen16,17,20,26,31, hyaluronic acid
(HA)15,18 and its chemical derivatives32–34, agarose35,36,
alginate25,37–41, or chitosan42. Some others are synthetic
degradable polymers, such as polyesters (e.g. polylactic
acid, polyglycolic acid)21,23,43,44, polyethylene oxide45 or
injectable polymers like poly(ethylene glycol)46,47.
The addition of growth factors (e.g. IGF-1, bFGF, TGF-
beta-1 or BMP-2)48–50 in implanted materials constitutes a
new field of investigation aiming at an enhanced efficacy.
Recently, Caterson et al.51 observed a best chondrogenic
differentiation of bone marrow-derived cells seeded in a
poly-L-lactic acid/alginate three-dimensional scaffold
treated with TGF-beta-1. The ability of growth factors to
differentiate stem cells into chondrocytes and to form
cartilage has been clearly shown, but efficient and
harmful doses still have to be specified before that human
applications can be envisaged.
In the present work, several biomaterials have been
investigated for cartilage substitution in an animal model.
The goal was to repair full-thickness defects of rat articular
cartilage. Similar lesions in man are known for their spon-
taneous evolution to OA. The assessment of various filling
materials (hybrid sponge, gels and sponges withoutcells) was performed according to clinical, histological and
biochemical criteria.
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control group of N=13 animals without defect were used for
the study. Joint defects were treated according to different
procedures: in the spontaneous repair group (SR) no
scaffold was introduced (N=18). In HA-gel groups, lesions
were filled with HA12 gel (N=18) or HA18 gel (N=18). In
sponge groups, lesions were repaired by a piece of Alg
sponge (Asp) (N=18), Alg combined with HA sponge
(AHAsp) (N=18) or Hybrid sponge (HYBsp) (N=18). During
the experiment, the body weight of implanted and control
animals was monitored at various intervals.
Sacrifice occurred at days 10, 20 and 40, and both knees
were collected. In every group of six rats, four were used
for biochemical analysis and two for histological assess-
ment. Synovial fluids were collected by absorption on filter
papers. The repaired areas were macroscopically
assessed according to a semi-quantitative scale, as
described in Table I.HISTOLOGICAL EVALUATION
Histological routine methods, involving 3 days fixation in
formalin (10% v/v in formaldehyde, pH 7.4) (Sigma,
France), followed by 3 weeks decalcification in ethylene
diamine tetracetic acid (Merck, Germany) (10% v/v in
formalin), were used. After dehydratation, joints were
embedded in paraffin and cut on a rotary microtome at
5 m sections. These sections were stained with Hema-
toxylin Eosin Safran (HES) for global anatomic analysis,
with Toluidin blue for proteoglycans staining and with Sirius
red for collagen network architecture. Slides were gradedby two operators in the same conditions. A semi quantita-
tive scale, adapted from Caplan et al.2, with new assess-
ment criteria concerning remnants of implanted matrix
(HES staining) and collagen architecture (Sirius red stain-
ing examined under polarized light), was used. With this
latter staining, normal hyaline cartilage was structured in
three layers: a thin superficial red, an intermediate black
and a thick deep green, accompanied by Gothic arcs
surrounding dark spaces for chondrocytes. Moreover, the
Toluidin blue staining of the matrix was evaluated as a
percentage of the matrix staining measured on control
animals of the same age, by digital computer (N.I.H. picture
v1.62, W. Rasbaud, National Institute of Health, U.S.A.).
The whole staining and digital session were performed on
the same day by a single operator. Addition of all items,
except remnants of matrix (irrelevant for the SR group), led
to a total score on 20, as described in Table I.Table I
Macroscopic and histological evaluation of tissue repair, 10, 20 and 40 days after implantation of biomaterial
(HA12 and HA18: HA derivatives obtain by grafting of alkyl chains C12 or C18; Asp: alginate sponge; AHAsp:
alginate sponge combined with HA; HYBsp: alginate sponge combined with HA and autologous chondrocytes) or
spontaneous repair (SR)
Group Day N Macroscopic
score/12 (1)
N Histological
score/20
(2)
Statistics
(3)
SR 10 3 3.3±0.9 4 4.5±1.2
20 3 2.0±1.0 4 9.0±3.0 NS
40 4 9.2±0.7 2 10.5±1.5
HA12 10 3 4.3±2.4 2 9.5±1.5
20 4 3.0±0.7 4 7.5±1.4 NS
40 3 10.3±1.2 4 7.7±1.8
HA18 10 4 5.2±1.0 2 8.0±1.0
20 4 4.0±0.9 2 9.5±1.5 ***
40 4 10.7±1.0 4 11.5±1.2
Asp 10 3 3.0±2.1 4 5.5±2.9
20 4 2.2±0.8 4 9.7±1.4
40 3 6.0±2.1 2 8.5±2.5
AHAsp 10 3 1.7±1.2 4 4.7±1.5
20 4 3.0±0.7 4 11.5±1.3 *
40 3 10.7±0.9 4 10.2±1.3
HYBsp 10 4 6.7±1.8 4 4.7±1.5
20 4 6.5±1.7 2 8.0±1.0 **
40 4 9.7±1.1 2 14.0±1.0
(1) Global macroscopic score/12: means±S.E.M. issued from N animals observed for five parameters (surface
regularity/2, resurfacing/3, junction aspect/2, repair aspect/2 and fill up/3).
(2) Global histological score/20: means±S.E.M. issued from N observations realized by two manipulators for
eight parameters (cell morphology/4, subchondral bone/3, filling/2, surface regularity/1, junction/2, proteoglycan
staining/4, collagen fibers/4).
(3) Data were analysed in a two-way ANOVA (groups vs macroscopic and histological scores) and significance
of differences (Asp vs other groups) is set at P<0.05; ND: non-determined; NS: non-significantly different;
P<0.05*; P<0.02**; P<0.01***.BIOCHEMICAL EVALUATION
In order to evaluate the quality of repaired cartilage, fast
turnover components, HA and sulfated glycosaminogly-
cans (GAGs), were measured. After macroscopic assess-
ment, different zones of femoral cartilage (repaired zone
and weight-bearing cartilage) were collected with a 2 mm Ø
biopsy punch. Each patella was decalcified in 1.5 ml of 5%
formic acid (Merck, Germany) for one night before its
cartilage was peeled. The samples were dried overnight at
37°C (one punch for the repaired zone, six punches for
weight-bearing cartilage, and 0.5 to 1.5 mg of cartilage for
patella). They were digested at 60°C during 24 h by 10 l of
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200 l of buffer (pH 6) [20 mM anhydrous Na2HPO4(Merck, Germany), 1 mM EDTA (Merck, Germany) and
2 mM dithiothreitol (Sigma, France), completed to 100 ml
with distilled water]. Hydrolysis was stopped by addition
of 10 l of 220 mM sodium monoiodoacetate (Merck,
Germany). Then the volume was adjusted to 400 l with
50 mM Tris-HCl (pH 8) buffer (Merck, Germany).GAGs analysis
The assay is based on the ability of GAG’s sulfate
groups to bind to the cationic dye dimethylmethylene blue
(DMB) at pH 358. At the concentrations used, there was no
interaction with alginate, when present in solution59. 100 l
of papain-hydrolyzed samples were added to 2.5 ml of
DMB [0.016 g/l of DMB (Aldrich, France), 3.04 g/l of glycine
(Sigma, France), 2.37 g/l of NaCl (Sigma, France), 95 ml/l
of 0.1 M HCl (Merck, Germany)]. Quantification of GAGs
was performed using a reference curve, constructed in the
same conditions with chondroitin 4S (0.25 to 10 g/ml)
(Sigma, France).DNA analysis
The fluorimetric assay used was previously described by
Lipman60. Briefly, 25 l of papain-hydrolyzed solution were
added to 25 l of buffer (pH 7.4) (10 mM Tris-HCl, 1 mM
EDTA, 0.1 M NaCl) and 2 ml Hoechst Dye 33258 (0.1 mg/
ml) (Hoechst, Germany). Readings, performed at
exc=356 nm and em=458 nm, were compared to a
reference curve constructed with calf thymus DNA (0.01 to
2 g/ml) (Sigma, France).Unsaturated disaccharides analysis in cartilage
Unsaturated disaccharides of chondroitin (diC4S,
diC6S) and hyaluronic acid (diHA) were analysed by
capillary zone electrophoresis as described by Payan et
al.61. Briefly, 25 l of chondroitinase ABC (1 UI/l) (Sigma,
France) and 150 l of Tris buffer (pH 8) were added to
225 l of papain-hydrolyzed samples. The mixtures were
maintained at 37°C overnight. 250 l aliquots were then
filtered on Ultrafree-MC (Millipore, U.S.A.) at 10 000 g for
1 h. 150 l of the filtrates, diluted or not in Tris buffer, were
completed with 10 l of internal standard solution. Un-
saturated disaccharide levels were estimated vs a cali-
bration curve established with a standard mixture of
diC4S and diC6S purchased from Sigma (France) and
diHA obtained after enzymatic hydrolysis of rooster comb
Hyaluronate (Sigma, France).Determination of HA in synovial fluids
This analysis was performed using a high-performance
liquid chromatography method described by Payan et al.62.
Filter papers with absorbed synovial fluids were placed in
100 l of 0.9% NaCl and 10 l of Streptomyces hyaluroni-
dase 100 UI/l (Sigma). Then, 100 l of 20 mM acetate
buffer (pH 6) were added. After 48 h of hydrolysis at 20°C,
10 l of internal standard solution were added. HA stan-
dards at different concentrations were prepared similarly to
establish the calibration curve.STATISTICAL ANALYSIS
Data were expressed as mean±standard error of the
mean (S.E.M.).
Residual percentage of HA in left or right knee of treated
groups are obtained by the following relation [1]:
One or two-way ANOVA was used to determine the
statistical significance of the differences observed at
various times between left and right knees of the different
groups. P values smaller than 0.05 were considered
significant.ResultsBEHAVIOURAL STUDY OF THE ANIMALS
The follow-up of animals by biotelemetry was performed
during 10 days after the implantation. No major variations
of the mobility and the body temperature of animals (36–
38°C) were evidenced during this period.
A slight decrease of the rat activity, likely due to the
general anesthesia conditions used, was observed during
the first 48 h after the surgical intervention. All animals
proved to move without handicap during their displace-
ments, owing to the localization of implanted lesions in a
non-load-bearing area (femoral trochlea).
Animals were weighed at regular intervals throughout
the experiment. The average weight of the implanted rats
was identical to that of the same age control group, at all
measuring times from day 0 to day 40. The rats were
therefore capable of standing up on their implanted legs in
order to eat and to drink.MACROSCOPIC AND HISTOLOGICAL ANALYSES OF THE REPAIR
TISSUE
The visualization of repaired areas shows an optimal
filling of the defect since D20 for HA18, and HYBsp (Fig. 1).
In contrast, this filling is never complete for other bio-
materials. The global macroscopic score obtained for gel-
repaired defects was similar to that of sponge-repaired
ones (Table I). These results were confirmed by the global
histological score (Table I) assessing anatomical perform-
ances of biomaterials. For all groups, this score improved
with time. As for macroscopic assessment, HA18 had the
best histological score at D40 among gels (HA18 11.50/20
and HA12 7.75/20). Among sponges, HYBsp had the best
score at D40 (14/20 compared to Asp 8.50/20 and AHAsp
10.25/20) (Fig. 2).
The histological study has shown that at Day 40, hyaline-
like areas were present only in HA18 and HYBsp groups
[Fig. 3(a), (c) respectively]. Moreover, proteoglycans
staining was superior in the HYBsp group.
The sponges were slowly degraded and remained visible
after D40, as small fragments surrounded by collagen
fibers [Fig. 3(d)]. Chondrocyte-like cells were visible inside
those fibers.
For HA18 or HYBsp, repaired tissue tends to turn hyaline
with time, with increasingly numerous cells and organized
collagen fibers [Fig. 3(b), (d) respectively].
CELL REHABITATION
DNA measurements in repaired zones conﬁrmed the
presence of cells in the different materials. Since D10, DNA
levels recovered in the trochlea of surgically-treated knees,
whatever left repaired or right control, are similar to those
observed in trochlea of absolute controls (CG) (2.0±0.3 g/
punch; N=25).
HA ANALYSIS
This analysis was performed on the synovial ﬂuid and on
a calibrated punch of trochlea, taken from both left and right
knees of animals, implanted or not (self-repair) and from
control animals left without any surgical intervention. At Day
10, 20 and 40, whatever the sample, average HA amounts
in the synovial ﬂuid of absolute controls (CG) (3.3±0.4 g/
joint for N=20) were not signiﬁcantly different of those
taken from control right knees of operated animals (Fig. 4)
[varying from 1.8±0.3 g/joint (N=4) to 4.6±0.6 g/joint
(N=4)].
In control right trochlea of treated rats, the percentage of
residual HA, calculated with the relation [1], varied by a
factor 0.5 to 1, as compared to the average value estimated
for animals of the CG group (1.6±0.1 g/punch) (Fig. 4).
For these synovial ﬂuid and trochlea control samples, HA
ratios remained relatively stable with time since no signiﬁ-
cant difference was evidenced between days 10, 20 and
40.
Signiﬁcant differences in synovial HA were observed,
depending on the nature of the treatment (self repair or
scaffold implantation). Alginate-based sponges and SR
samples single out more particularly since average
synovial HA may reach values from 5.0±1 g/left joint
vs 2.7±1 g/right joint up to 10.3±2.0 g/left joint vs
4.6±1.2 g/right joint, at D40 on the implanted left side.
This HA hyperproduction suggests that, in these repair
conditions, the metabolism is disturbed. This phenomenon
is not observed with HA12 and HA18 samples, indicating
that there is no massive release of these polymers in the
joint cavity, triggering undesirable local effects.
HAmeasurements in repaired trochlea clearly evidenced
an hyperproduction of this polysaccharide at day 10, reach-
ing values more than three-fold higher than those of abso-
lute controls (CG) (Fig. 4). Such HA amounts in repaired
areas can only result from a colonization of the biomaterial
by neighbouring cells capable of synthesizing HA. For all
samples, HA amounts decreased with time to reach normal
values at day 40.
GLYCOSAMINOGLYCANS ANALYSIS
Amounts of total sulfated glycosaminoglycans (GAGs)
as well as chondroitin sulfates 4S to 6S ratios were
Fig. 1. Macroscopic analysis of repaired areas (×10). Bad surface reconstruction with the SR group at D10 and D40. Good resurfacing with
HA18-gel at D40. However, at the view of respective stainings, the repaired zone is still distinguishable from native cartilage. Optimal
resurfacing for HYBsp group at D40.
Fig. 2. Comparison of macroscopic score/12 (right axis) and
histological score/20 (left axis). Data are presented as a
mean±S.E.M. for N observations and ﬁve parameters (macroscopic
score) or N observations and eight parameters (histological score),
respectively, performed by two manipulators (see Table I).
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evaluated in the various zones (controls or repaired) of joint
cartilage (trochlea, condyle and patella).
For all groups, data obtained for control right knees of
treated animals were systematically compared to those of
the CG group, in order to take into account the potential
individual variations, and also to appreciate a possible
long-range effect of biomaterials and/or surgery on other
cartilage sites surrounding the implant.
GAGs levels observed in repaired trochlea at D10 are
signiﬁcantly different of those determined in right knees in
the whole group of treated animals (Fig. 5). Whereas in the
SR, HA12 and HA18 groups an incomplete matrix syn-
thesis is observed, AHAsp and HYBsp implants lead to a
matrix hyperproduction (Fig. 5). This phenomenon sug-
gests a superiority of HA-based sponges, as compared to
the HA-gels, that can be attributed to their porous structure.
For the HYBsp group, the ﬁfteen days of in vitro matrix
preparation before its implantation leads to an increase of
the GAGs levels in the repaired zones of this group. Owing
to the large individual variability of this parameter in control
knees as well as in treated ones, no clear-cut conclusion
can be discerned. Such variability makes this parameter
inappropriate as only criteria to appreciate the quality of
cartilage repair with biomaterials, whatever their nature.
The measurement of chondroitin sulfates, especially
their 4S to 6S ratios appears as a more discriminative
parameter. This indicator is signiﬁcantly different for all
samples of operated animals, for the repaired trochlea and
for the patella facing them (Fig. 6). Whatever the repair
mode, self-repair or scaffold, hydrogel or sponge, hybrid
material, presence or absence of HA, this indicator, which
varies with the age of animals, never reached the values
obtained neither with the absolute control (CG) (D10:
22.0±2.4; D20: 18.0±1.2; D40: 12.6±0.8) or with the
control knees of opposite legs (Fig. 6).
The hybrid implant of the HYBsp group systematically
disturbed the diC4S/diC6S ratio of both left and right
sides, suggesting a paracrine effect of this type of implant.
In repaired trochlea, the decrease of the diC4S/diC6S
ratio was due to the variation of the chondroitin 4S, sys-
tematically inferior in the treated knee. In contrast, in the
case of patella, this ratio was different owing to a signiﬁcant
increase of the chondroitin 6S, as compared to that in
control knees.
Discussion
The present work focused on the in vivo study of
cartilage repair in the presence of various polysaccharidic
scaffolding biomaterials. The diversity of repair processes
proposed in the literature and of tools of assessment is a
major drawback which led us to envisage the study on our
various biomaterials within a single experimental rat model
and using the same investigation tools. The capacity of
hydrogels or sponge materials to repair a focal lesion of
cartilage was evaluated. Also, the potential interest of the
incorporation of hyaluronate or autologous chondrocytes
was investigated.
All ﬁlling materials, except one (Asp), were prepared with
HA or its hydrophobic derivatives. HA is a non-sulfated
polysaccharide of the natural cartilage matrix. It forms
aggregates of proteoglycans via a link-protein. It can also
bind chondrocytes through receptors (CD44 for example),
thus improving cellular adherence and cell-matrix inter-
actions1,15,18,32. Hydrophobic derivatives used in this study
were obtained by chemical modiﬁcation of native HA, in
order to enhance its rheological properties52,53.
Sponges were prepared with alginate (Alg), alone or
combined to HA. Alg is a polysaccharide widely used for its
Fig. 3. Histological analysis of repaired areas (×40) at D40, for HA18 gel implant (a) and (b) and HYBsp (c) and (d). (a) HES staining: visible
gel colonized by some cells (lower layer); a few zones of hyaline tissue (upper layer); remnants of gel surrounded by ﬁbrocartilage
(intermediate layer). (b) Sirius red staining examined under polarized light conﬁrms the presence of organized collagen ﬁbers. (c) HES
staining: visible sponge with numerous cells (lower layer); ﬁbrocartilage zones are still distinguishable in the intermediate layer. (d) Sirius red
staining examined under polarized light: some collagen ﬁbers are visualized in the vicinity of the native cartilage.
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22 Y. Dausse et al.: Cartilage repair using new biomaterialsFig. 4. HA measurements in synovial fluid and trochlea of both knees at D10 ( ), D20 ( ) and D40 ( ). Analysis of HA is described in the
Materials and methods section. The mean value of synovial fluid HA is expressed in g of HA/joint and is obtained from left and right knees
of the CG group (· · ·). Residual percentages of HA in trochlea are calculated from relation [1] (see Materials and methods). Data are
expressed as a mean value±S.E.M. for N=4. Statistic analysis is performed by two-way ANOVA to test the significant difference between right
and left knees of both groups with P<0.05*; P<0.02**; P<0.01***.excellent structural properties: in the presence of divalent
cations (Ca2+), it forms a cohesive and firm gel, the
properties of which vary with the viscosity, purity and
source of the powder, as well as with the method of gel
preparation. The optimal proportion of HA/Alg mixtures was
defined by Oerther et al.54, to obtain a gel mimicking the
hydrated and viscoelastic environment afforded by the
extracellular matrix embedding the chondrocytes. When
this gel is prepared as a sponge, both a microporous
network and an open macroporous one are obtained.
Miralles et al.40 have shown that the existence of such a
macroporous network is in favor of cell colonization and is
well adapted to the in vitro biosynthesis of an extracellular
matrix.
In this study the macroscopic and histological obser-
vations were compared to specific biochemical parameters
of cartilage, in order to appreciate the relevance of these
latter as discriminating criteria of assessment.
The behavioural approach evidenced a normal progres-
sion of the animal weight, whatever the treatment,
and a good tolerance to biomaterials which obviously did
not induce any major handicap or/and inflammatory
phenomena that can be visualized by biotelemetry.
However, in some groups, the synovial HA proved to
significantly increase. According to the literature, excess
of HA in the synovial fluid would be due an enhancedproduction by synoviocytes, in relation with articular in-
flammation63,64. Our results were consistent with this
observation.
In fact, synovial HA is increased in the SR group, in
concordance with the inflammatory process, widely
reported to occur during the spontaneous repair20,65,66. It
starts on the first week of the repair66 and could be
responsible for the weak stability of the neosynthesized
tissue2,63.
Significantly higher HA levels in Asp samples and, to a
lesser extent, in AHAsp and HYBsp, can be correlated to
recent works reporting on the stimulating effect of alginate
on the production of IL-1 by monocytes67. In fact, even
though alginate is considered as a fully compatible poly-
mer41, its mannuronic acid residues could stimulate the
production of inflammatory cytokines (among which IL-1)68.
This cytokine may activate the production of HA in the joint
upon stimulation of endogenous cyclo-oxygenases69.
In contrast, hydrogels only based on HA do not seem to
cause this type of reaction. In fact, in certain conditions, HA
has inhibitor effects on the production of IL-1 (air pouch
model)70 and may play a retro-control role on the produc-
tion of this cytokine, in synergy with exogenous HA.
Solchaga et al.71 and Barbucci et al.72 showed that, in
addition, HA most often improves the biocompatibility of
materials to which it is associated. These two elements,
Osteoarthritis and Cartilage, Vol. 11, No. 1 23Fig. 5. GAGs measurements at D10 and D40 in trochlea of left and right knees for both groups. Analysis of GAGs is described in Materials
and methods. Data (g/punch) are expressed as a mean value±S.E.M. for N=4 from left ( ) and right knees ( ) of both groups. Statistic
analysis is performed by one-way ANOVA, to test the significant differences between right and left knees of each group with P<0.05*;
P<0.01***; P<0.001****.inhibition of IL-1 production and biocompatibility improve-
ment, are in favor of better tissue reconstruction and
scaffold integration.
The macroscopic aspect of the repair only accounts for
the surface of a much deeper healing process. At day 10,
during the inflammatory phase, a translucent, soft and
gelatinous, fibrous tissue covers the surface of the defect. A
similar aspect was previously reported by Kawamura20.
This fibrous tissue starts forming from the defect’s borders
and progressively spreads inwards to fill the lesion, with a
central zone looking like a crater. Once the surface was
entirely covered, the soft tissue maturated and became
white opaque15,33. As previously reported in another work,
the repaired zone at the end of our study was usuallyclearly distinguishable from the native surrounding
cartilage15. However, with certain samples, especially
HA18, the repaired zone had a normal consistence and
appearance.
As seen from the global histological results, the quality of
the repair tissue and its integration to adjacent cartilage
was sometimes disappointing. This fact is commonly
reported in the literature, for studies with various materials
or methods. For example, in agreement with the obser-
vation of Rahfoth et al.35, we noted that the junction may
vary from an intimate connection to a gap. Indeed, these
critical factors could compromise the long-term evolution
of the repair66. Since D10, numerous inflammatory or
fibroblast-like cells colonized the gels, as confirmed by
24 Y. Dausse et al.: Cartilage repair using new biomaterialsDNA analysis in the repair area. Some authors already
observed such an invasion with other hydrogels15,18. The
hydrogel disappeared slowly and was replaced by a fibrous
tissue which progressively turns to fibrocartilage or even
ultimately to a hyaline tissue20. This sequence was similar
to the spontaneous healing of acute cartilage defects3,4,63,
but extended to the whole implanted gel. Hunziker5,63 has
previously noticed this phenomena with another gel and a
fibrin clot.
In the case of unseeded materials, the assessment of
DNA content in repaired zones is unfortunately not a
suitable criteria to discriminate which cellular type,
chondrocytes or other cells involved in the matrix biosyn-
thesis, has invaded the lesion or the material. Synoviocytes
would be good candidates for this cell rehabitation and
have already been proposed by Hunziker5,49,63. Enhanced
hyaluronate levels observed in repaired zones filled by
unseeded materials are in strong support of this hypoth-
esis. Such an overproduction of hyaluronate has been
evidenced by Lammi et al.73 during the repair of deep
lesions. The weaker variation noted for the HYBsp group is
likely due to the preliminar in vitro matrix synthesis by
autologous chondrocytes, leaving only little opportunity to
neighboring cells to invade the pre-formed implant.
The rat model of cartilage lesion used in this work
enabled us to compare the histological results with the
quantitative evaluation of GAGs. After the massive cellular
colonization of unseeded materials, the presence of proteo-
glycans in repaired zones is observed, whatever the type of
material and the nature of invading cells41, which obviously
recover their capacity to synthesize proteoglycans74. In the
sponges, cells could profit of the large porosity of these
materials to synthesize a GAGs-enriched extracellular
matrix. Indeed, Chen et al.75 and Solchaga et al.71 have
reported that a macroporous open network allows for an
abundant synthesis of extracellular matrix. Freed et al.21
made the same observation with polylactic or polyglycolicsponges, where human or bovine chondrocytes proved
capable of synthesizing a proteoglycan-rich matrix.
The presence of a sufficient amount of GAGs constitutes
a strong advantage with respect to the long-term stability of
the repair, as observed by Frenkel et al.16 with a porous
collagen matrix.
In our work, the association of a porous alginate sponge
with HA, a biological agent involved in proteoglycan syn-
thesis76,77 and with the seeding of autologous chondro-
cytes, leads to an optimal repair. In fact, the GAGs-rich
extracellular matrix was preliminary obtained in vitro with-
out cell multiplication in monolayer cultures, in contrast with
the majority of authors16,17,20,33,35. These conditions have
for advantage to avoid the dedifferenciation of chondro-
cytes and their synthesis activity for a type I collagen
matrix.
However, histological assessments as well as GAGs
measurements seem insufficient to specifically estimate the
quality of the repair tissue and its similarity with native
cartilage. Very few works attempt to correlate the synthesis
of chondroitin sulfates, and especially their 4S to 6S ratios,
with the quality of the neo-formed tissue. This ratio, which
depends on many parameters such as the species, the
localization in cartilage78 and the age79, varies with the
cartilage maturation, accompanied by a chondroitin 4S
decrease79. However, the position 4 or 6 of the sulfate
group is actually concerned by two sulfotransferases, the
mechanisms of action of which are not yet well known79.
This parameter actually appears in our study as an
important indicator. It showed that, despite the macroscopic
and histological encouraging results observed with HA18
and HYBsp, the cartilaginous matrix obtained has not yet
reached its optimal composition 40 days after the implan-
tation. This is in agreement with the conclusions of various
authors on other biomaterials80.
In opposition with what is commonly suggested in many
works, our in vitro preparation of a re-implantable artificial
cartilage (HYBsp group) did not allow to reach a normal
tissue more rapidly. 40 days after the implantation, the
composition in chondroitin 4S and 6S is still at variance with
that of the native matrix. Moreover, this type of implant
leads to metabolic modifications of the whole surrounding
cartilage. This phenomenon could be attributed to the
conditions of the preliminary culture, which could lead to an
implant able to provoke a transient inflammatory reaction.
This latter would induce some increase of circulating pro-
inflammatory mediators, some of which are already well
known to disturb the cartilage metabolism and especially
the synthesis of proteoglycans81.
The other unseeded repair biosystems have a lesser
influence and only modify the chondroitin sulfates 4S to 6S
ratio of the patella localized in front of the repaired zone.
This modification is probably due to the enhanced
metabolic activity in the articular cavity during the repair
process82.Fig. 6. Evaluation of diC4S/diC6S ratios in trochlea and patella
facing it, of left knees for both groups, at D10 ( ), D20 ( ) and D40
( ). Data are expressed as mean value±S.E.M. for N=4. Statistic
analysis is performed by two-way ANOVA to test the significant
difference between implanted or SR groups and control group
(CG) with P<0.01*** P<0.001**** (ND: non determined).Conclusion
The present work enabled us to compare macroscopic,
histological and biochemical parameters, in order to evalu-
ate different types of materials with a single experimental
model of cartilage defect. It evidenced that, even though
the macroscopic and histological criteria received positive
appreciations for certain biomaterials, notably a HA-based
hydrogel and a hybrid HA-enriched alginate sponge, the
biochemical parameters should be considered as well to
Osteoarthritis and Cartilage, Vol. 11, No. 1 25appreciate properly the intrinsic quality of the repair tissue.
The follow-up of endogenous hyaluronate and chondroitin
sulfates, should be completed in the future by the qualita-
tive and quantitative analysis of collagens in the neo-
synthesized tissue. In addition, the knowledge of local or
systemic contents in pro-inflammatory cytokines such as
TNF-, IL-1 or IL-6, would be of great importance to explain
the metabolic changes noted in the cartilaginous tissue
during the repair process.Acknowledgments
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Chondroitins 4S and 6S valued in trochlea and patella issued from treated and no treated animals at D10, D20 and D40 of repair (N=4 per
group)
Days Trochlea Patella
di6S g/punch Statistics di4S g/punch Statistics di6S g/mg Statistics di4S g/mg Statistics
Right Left
Right
vs left Right Left
Right
vs left Right Left
Right
vs left Right Left
Right
vs left
CG 10 1.53 1.49 32.44 31.17 2.23 2.34 45.53 49.15
0.03 0.38 2.76 6.04 0.52 0.52 9.18 4.93
20 1.18 1.07 NS 21.64 19.33 NS 2.52 2.80 NS 43.65 42.11 NS
0.11 0.07 1.1 1.56 0.41 1.01 4.38 8.27
40 0.88 1.02 11.04 12.32 5.61 6.19 68.76 64.19
0.02 0.12 0.51 1.89 0.98 0.95 10.22 9.7
SR 10 1.49 0.87 31.26 7.93 2.14 4.27 51.49 44.19
0.31 0.22 5.40 1.96 0.26 0.69 4.34 3.69
20 0.88 1.11 NS 14.22 10.23 ** 2.61 3.18 *** 43.92 38.33 NS
0.17 0.07 2.51 3.37 0.45 0.52 10.89 2.99
40 1.26 2.08 15.29 17.70 2.70 3.47 38.21 30.57
0.20 0.68 2.38 5.35 0.09 0.64 1.91 1.35
HA12 10 1.71 1.55 39.90 14.61 2.96 4.42 52.93 44.59
0.11 0.19 2.74 4.65 0.34 0.32 6.79 3.43
20 2.14 2.63 NS 42.10 38.65 *** 2.61 3.47 *** 40.61 34.67 NS
0.09 0.24 1.56 3.81 0.28 0.59 5.64 3.41
40 1.01 1.77 12.32 13.15 2.70 3.81 29.76 31.81
0.20 0.68 3.45 2.61 0.31 0.68 3.42 2.06
HA18 10 0.92 0.52 16.09 3.75 2.44 5.08 54.13 58.36
0.07 0.05 0.68 0.84 0.24 0.53 6.74 7.57
20 0.68 0.90 NS 11.17 9.59 * 3.16 4.15 NS 47.76 50.12 NS
0.04 0.10 1.33 0.86 1.17 1.60 12.39 12.52
40 0.59 2.01 5.60 11.73 3.45 3.77 44.07 32.81
0.01 0.77 0.53 3.05 0.21 0.33 5.32 3.70
Asp 10 0.86 ND 10.54 ND 2.47 3.58 57.05 40.17
0.07 2.49 0.16 0.54 7.27 0.59
20 1.10 1.12 10.92 6.70 2.95 5.03 52.69 60.12
0.16 0.05 NS 2.01 0.30 ND 0.49 0.79 *** 3.07 1.47 NS
40 1.09 1.27 9.72 11.24 3.09 4.53 45.25 39.43
0.15 0.16 0.38 1.98 0.39 0.96 6.15 3.34
AHAsp 10 0.97 1.39 15.25 7.49 3.16 4.50 62.97 58.08
0.06 0.32 0.67 2.79 0.39 1.09 4.90 8.15
20 1.60 1.60 NS 20.20 12.46 * 3.37 5.46 ** 60.80 52.56 NS
0.37 0.13 2.64 1.18 0.63 1.25 8.65 7.19
40 1.10 1.46 12.01 13.02 1.59 2.71 22.82 24.83
0.17 0.27 2.54 4.12 0.28 0.38 1.71 1.53
HYBsp 10 1.78 1.21 22.60 11.14 1.50 2.53 25.16 31.79
0.21 0.18 1.31 4.50 0.16 0.14 2.08 2.27
20 1.75 1.12 ** 13.72 3.33 **** 2.20 4.25 **** 22.86 27.37 NS
0.07 0.28 1.78 1.64 0.28 0.23 2.68 1.29
40 3.32 2.31 18.08 13.28 2.30 3.42 22.10 19.24
0.62 0.27 3.73 1.41 0.11 0.12 0.56 2.84
Data were analysed in a two-way ANOVA and significance of differences (right vs left) is set at P<0.05.
ND: non-determined; NS: non-significantly different; P<0.05*; P<0.02**; P<0.01***; P<0.001****.References
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